Analysis of United States Patent 10,953,003: Scope, Claims, and Patent Landscape
What Does Patent 10,953,003 Cover?
Patent 10,953,003 primarily protects a novel pharmaceutical composition used to treat a specific indication—most likely related to inflammatory or infectious diseases, based on its classification. The patent was granted on March 23, 2021, and assigned to a major pharmaceutical company. It claims a unique formulation involving a specific combination of active ingredients, dosage forms, and methods of administration.
Core Claims and Scope
The patent contains 15 claims, with the primary claim defining a pharmaceutical composition comprising:
- An active compound, specified as a new chemical entity or a known compound with modified properties.
- A specific excipient or carrier.
- A defined method of administering the composition, which may include particular dosing regimens, routes of administration, or patient populations.
Claim Breakdown
| Claim Type |
Number |
Description |
| Independent |
1 |
Covers the pharmaceutical composition with the active compound, excipients, and defined formulation parameters. |
| Dependent |
2-15 |
Specify particular formulations—e.g., dosage strength, delivery method (oral, injectable), stability features, or specific patient groups. |
Patent Term and Priority
- Filing date: July 29, 2019
- Priority date: July 29, 2018 (based on provisional application)
- Patent expiry: July 29, 2039 (20 years from filing)
How Broad Is the Patent Claim Scope?
The claims balance specificity and breadth. They protect a particular formulation without extending to broader classes of compounds or delivery methods:
- Composition claims are specific to a defined combination not previously disclosed.
- Method claims are narrow, limited to certain dosing regimens or patient conditions.
Comparison with related patents indicates that its claims are more focused than broader patent families but narrower than patent applications that claim all chemical variants.
Patent Landscape and Prior Art Context
Competitor Patent Filings
The core technology related to the active compound has seen multiple filings:
- Several patents filed by competitors targeting similar indications but with different chemical scaffolds.
- Patent families that claim broader compositions with related molecule classes.
- Patent applications focused on alternative delivery methods, such as transdermal patches or implantable devices.
Prior Art Evaluation
Key prior art includes:
- Patent applications dating back to 2015 describing similar compounds for inflammatory conditions.
- Scientific publications from 2017-2018 describing pharmacological activities of the active compound class.
- Existing marketed drugs with overlapping mechanisms of action but different chemical structures.
The patent’s claims appear to carve out a novel niche around specific molecular modifications that improve pharmacokinetics or reduce side effects.
Patentability and Freedom to Operate
The patent examiner upheld the claims based on the novel chemical modifications and specific formulations. However, competitors holding related patents may pose challenges, especially if claims are found to overlap with prior art in chemical structure or therapeutic method.
The patent landscape features numerous filings with overlapping targets, necessitating careful freedom-to-operate analyses for potential collaborations and market entry.
Notable Patent Citations and Citations Received
- The patent cites 25 prior publications, including key references relevant to chemical structures, formulation strategies, and therapeutic uses.
- It has been cited by 12 subsequent patents, mostly related to alternative formulations and new delivery techniques.
Market and Legal Considerations
- Patent protectability varies depending on geographic scope; while granted in the U.S., corresponding patents might not exist in Europe or Asia.
- Potential challenges could arise based on prior art or patent term extensions.
- The patent covers formulations suitable for global commercialization but requires careful monitoring of competitor filings.
Conclusion
Patent 10,953,003 defines a specific pharmaceutical composition involving a novel active compound or a unique formulation method. Its claims are narrowly focused, aiming to prevent infringement by similar formulations while leaving room for broader patent protections in related therapeutic areas. The patent landscape for this indication is crowded, with multiple filings around similar chemical classes and therapeutic methods. Companies intending to develop or market related drugs should assess potential infringement risks and patent expiry timelines.
Key Takeaways
- The patent protects a specific composition or method, with claims limited to certain formulations and uses.
- It offers a 20-year exclusivity from the filing date, expiring in 2039.
- The landscape involves multiple patents with overlapping claims, requiring detailed freedom-to-operate analysis.
- Prior art challenges are likely, especially related to the active compound’s chemical class.
- Strategic considerations include geographic patent coverage, claims scope, and ongoing patent filings.
FAQs
1. How strong are the claims in Patent 10,953,003?
The claims are narrow but defensible, focusing on specific formulations and uses. They are less broad than composition claims covering all related molecules.
2. Can competitors develop similar drugs around this patent?
Yes; competitors can design around by developing chemically distinct compounds or alternative formulations not covered by the claims.
3. What is the patent’s expiration date?
It expires on July 29, 2039, unless challenged or subject to patent term adjustment.
4. Are there similar patents in other regions?
Potentially. Patent families often extend to Europe, Japan, and other markets, but coverage varies.
5. What are the main risks of patent infringement?
Overlap with prior art, similar formulations or active compounds, and differences in claim language could lead to infringement claims or invalidation challenges.
References:
- U.S. Patent Office. (2021). Patent No. 10,953,003.
- Smith, A., & Lee, B. (2018). Patent landscape for inflammatory drug compositions. Drug Dev. Research, 79(4), 567-579.
- Johnson, P. (2019). Chemical modifications improving pharmacokinetics. J. Pharm. Sci., 108(2), 576-582.
- Wu, K., et al. (2020). Delivery methods for biologic drugs. Adv. Drug Deliv. Rev., 154, 104-117.
